OIT for Children: What Every Parent Needs to Know

There is a particular kind of dread that only parents of food-allergic children understand. The birthday party where every cupcake is a threat. The school lunch table that feels like a minefield. The constant, low-grade vigilance that seeps into every meal, every outing, every moment a well-meaning relative offers your child a snack.

You are not alone in carrying that weight. According to the CDC and Food Allergy Research & Education (FARE), roughly 5.3% of children in the United States have a diagnosed food allergy—about 1 in every 13 kids. That means in a typical classroom, two or three children are living with the risk of a severe allergic reaction every single day. Approximately 40% of those children are allergic to more than one food, compounding the restrictions their families navigate.

For decades, strict avoidance was the only advice doctors could offer. But oral immunotherapy (OIT) has changed the landscape. This physician-supervised treatment gradually trains a child's immune system to tolerate a food allergen rather than react to it—and a growing body of research shows that it works especially well when started early in life.

The Safety Profile of OIT in Children

The question parents ask first is always the same: is it safe? It is a fair question, because OIT involves giving an allergic child the exact food they react to. The answer, supported by years of clinical data, is that OIT carries manageable risks and a strong safety record when performed under proper medical supervision.

A study published in the Journal of Allergy and Clinical Immunology examining the safety of multifood OIT in children aged 1 to 18 years found that of all home doses administered during the first year of treatment, only 1.4% resulted in adverse events. Of those, 79% were classified as mild—symptoms like transient mouth itching or a brief stomachache that resolved without intervention. Across the entire cohort, only three doses of epinephrine were administered at home to two patients.

The most common side effects parents should expect are:

• Oral itching or tingling — typically mild and temporary, often limited to the first few weeks of dosing
• Abdominal discomfort — stomach cramps, nausea, or occasional vomiting, most frequently during dose increases
• Skin symptoms — hives or eczema flares in a small percentage of patients
• Systemic reactions — rare, but the reason OIT must always be conducted under the care of a board-certified allergist with a clear action plan in place

The most common reason families discontinue OIT is persistent gastrointestinal symptoms, though this affects a small minority. Risk factors for more significant reactions during treatment include a history of severe initial allergic reactions, concurrent allergic rhinitis, older age at the start of treatment, and higher baseline allergen-specific IgE levels, according to a retrospective analysis of 653 preschool-age patients published in JACI: Global.

Key takeaway: The vast majority of OIT reactions in children are mild and self-limiting. Serious reactions are uncommon, and the risk decreases further when treatment starts at a younger age.

When to Start: Earlier May Be Better

One of the most important developments in pediatric allergy research over the past decade is the growing evidence that earlier intervention produces better outcomes. The landmark LEAP (Learning Early About Peanut Allergy) trial, published in the New England Journal of Medicine, enrolled 640 infants between 4 and 11 months of age who were at high risk for peanut allergy. The results were dramatic: among children who consumed peanut regularly from infancy, only 3% developed peanut allergy by age 5, compared to 17% of children who avoided peanut entirely—an 81% relative risk reduction.

The LEAP trial focused on prevention through early introduction rather than OIT treatment for established allergy, but the principle it established—that the young immune system is more receptive to tolerance—has shaped how allergists approach OIT timing. Follow-up data from the LEAP-On study demonstrated that this tolerance persisted even after a full year of peanut avoidance, and long-term tracking through adolescence confirmed durable protection.

For children who already have a diagnosed food allergy, these findings translate into a clear trend: starting OIT younger tends to yield higher rates of desensitization with fewer adverse events. The SmaChO (Small Children Oral Immunotherapy) randomized controlled trial, published in the Journal of Allergy and Clinical Immunology: In Practice, demonstrated a high degree of desensitization after just one year of early-life peanut OIT in young children, with the combination of slow up-dosing and low maintenance doses proving both safe and effective.

At EatFreely, our board-certified allergists treat patients as young as 8 months old. While the only FDA-approved OIT product (Palforzia) is indicated for children aged 4 to 17, individualized OIT protocols using measured food proteins can be administered to younger patients under specialist care. Many allergists now advocate for referral as soon as a food allergy is diagnosed, rather than adopting a wait-and-see approach.

Age considerations at a glance

• 8 months to 2 years: Youngest treatment window. Research suggests the immune system is most adaptable during this period. Toddlers often adjust to dosing routines quickly because they have fewer preconceptions about food.
• 2 to 5 years: Still an excellent window. Children in this age range tend to achieve desensitization faster than older children and have lower rates of adverse reactions during build-up.
• School age (5 to 12): OIT is highly effective in this group. Children are old enough to understand and participate in their own treatment, though integration with school routines requires planning.
• Teens (13 to 17): Successful treatment is still achievable, though adherence can be more challenging during adolescence, and baseline IgE levels are often higher, which can affect the pace of dose escalation.

What Daily Treatment Looks Like for a Child

OIT is not a one-time procedure. It is a daily commitment that becomes part of the family's routine, much like brushing teeth or taking a vitamin. Here is what that typically involves.

The clinical phase

Treatment begins with an initial day-long visit to the clinic, where the allergist administers a tiny dose of the allergen—often measured in milligrams—and monitors the child for several hours. If the initial dose is tolerated, the family begins daily dosing at home, returning to the clinic every one to two weeks for supervised dose increases (called "updoses").

Daily home dosing

Each day, the child consumes a precisely measured amount of the allergen mixed into a safe food. For younger children, this might mean stirring peanut flour into applesauce, mixing egg powder into pudding, or blending milk protein into a smoothie. The key requirements are:

• The dose must be consumed in its entirety—no skipping or partial doses
• Dosing should happen at roughly the same time each day
• The child must rest and avoid vigorous exercise for two hours after dosing
• A parent or caregiver should observe the child during and after the dose

Most families find that building dosing into a daily mealtime—breakfast works well for many—makes the routine sustainable. Young children often accept the dose without resistance, especially when it is mixed into a food they already enjoy. The dose itself is small, and the taste is typically undetectable in the carrier food.

The maintenance phase

After several months of gradual dose increases, the child reaches a maintenance dose—the target amount they will continue consuming daily. This is typically the equivalent of one to two peanuts, a small portion of scrambled egg, or a few ounces of milk, depending on the allergen. Maintenance dosing continues indefinitely to preserve the tolerance that has been built.

School and Daycare Considerations

Once a child on OIT enters school or daycare, parents need a plan that extends beyond the kitchen table. The daily dosing routine, the exercise restriction after dosing, and the need for emergency medications all have practical implications in a classroom setting.

504 plans and documentation

Under Section 504 of the Rehabilitation Act, children with food allergies qualify for accommodations at school. A 504 plan formalizes these accommodations in writing and is legally enforceable. For a child on OIT, the plan should address:

• The daily dosing schedule and whether dosing will occur at home or at school
• The two-hour exercise restriction after dosing and how that affects recess, physical education, or sports
• Where and how emergency medications (epinephrine auto-injectors and antihistamines) are stored
• Who on staff is trained to recognize and respond to an allergic reaction
• Any dietary accommodations in the cafeteria

Communicating with teachers and staff

Transparency is essential. Parents should meet with the child's teacher, school nurse, and administrators before OIT begins or before the school year starts to explain the treatment and its requirements. Practical topics to cover include:

• What OIT is and why the child is consuming a food they are allergic to (this often surprises school staff)
• Signs and symptoms of an allergic reaction and the correct response
• The importance of the post-dose rest period—and what activities are acceptable during that window
• Contact information for the allergist's office in addition to the family's emergency contacts

Daycare for younger children

For toddlers in daycare, most allergists recommend that all dosing occur at home under parental supervision. The daycare should still have the child's emergency action plan on file, along with unexpired epinephrine auto-injectors. Ensure the staff knows that the child is undergoing OIT and that occasional mild symptoms (like brief mouth itching) may occur and are not necessarily emergencies—while also ensuring they understand when to escalate.

What Parents Should Ask Their Allergist

Deciding to start OIT is a significant step. Before beginning treatment, parents should have a thorough conversation with a board-certified allergist who has experience in pediatric OIT. Here are the questions that matter most:

1. What is your experience with pediatric OIT? Ask how many children the practice has treated, what age ranges they work with, and what their success rates are. Experience matters in this field.
2. What allergens do you treat, and can you treat more than one at a time? Multifood OIT—treating multiple allergies simultaneously—is offered at some practices and can save families years of sequential treatment.
3. What does your up-dosing schedule look like? Different practices use different protocols. Slower up-dosing may reduce side effects. Understanding the pace helps families plan around clinic visits.
4. What happens if my child has a reaction? The allergist should provide a clear written action plan for managing reactions at home, including when to use antihistamines, when to use epinephrine, and when to call 911.
5. How long is the commitment? Maintenance dosing is ongoing. Parents should understand that OIT is not a short-term course of treatment but a long-term management strategy.
6. Is my child's allergy severity a concern? Children with very high IgE levels or a history of anaphylaxis can still be candidates for OIT, but the approach may differ. Some practices combine OIT with medications like omalizumab (Xolair) to improve safety during the build-up phase.
7. Does your practice accept insurance? OIT coverage varies by plan and by practice. Knowing the financial picture upfront helps families commit without surprises.